A307750 logo

Kookjeon Pharmaceutical Co., Ltd. Stock Price

KOSDAQ:A307750 Community·₩124.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A307750 Share Price Performance

₩2,310.00
-1715.00 (-42.61%)
₩2,310.00
-1715.00 (-42.61%)
Price ₩2,310.00

A307750 Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet with very low risk.

2 Risks
0 Rewards

Kookjeon Pharmaceutical Co., Ltd. Key Details

₩127.4b

Revenue

₩108.0b

Cost of Revenue

₩19.4b

Gross Profit

₩27.3b

Other Expenses

-₩7.8b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-145.40
15.25%
-6.16%
36.6%
View Full Analysis

About A307750

Founded
1972
Employees
178
CEO
Jongho Hong
WebsiteView website
www.kukjeon.co.kr

Kookjeon Pharmaceutical Co., Ltd. operates as a chemical total solutions provider in South Korea. It provides various chemical-based products and services; and after-sales services, such as research and development, production, quality control, and DMF services. The company manufactures active pharmaceutical ingredients; and offers molecular design and technical support. It develops electronic materials, such as antistatic agents, monomers and polymers with low dielectric constant, and UV curing agents; low-resistance electrolyte, phosphine, silane, and boron compounds; semiconductor materials; and carbazole, boric acid, and fluorene intermediates. In addition, the company owns patents for its manufacturing methods. It serves pharmaceuticals, intermediate products, new drug synthesis, and related materials industries. The company was founded in 1972 and is headquartered in Anyang-si, South Korea.

Recent A307750 News & Updates

Recent updates

No updates